Legislators: Bring all stakeholders to the table to lower drug costs Press Coverage Legislators: Bring all stakeholders to the table to lower drug costs BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…CertaraMarch 30, 2021
Strategic Evidence & Value Communication Symposium On-Demand Webinar Strategic Evidence & Value Communication Symposium Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…CertaraMarch 26, 2021
Leveraging a Compliant Data Repository to Significantly Improve Biostatistics Workflow Brochure Leveraging a Compliant Data Repository to Significantly Improve Biostatistics Workflow CertaraMarch 25, 2021
Purity is a Virtue: A Practical Guide to the Reporting of Impurities On-Demand Webinar Purity is a Virtue: A Practical Guide to the Reporting of Impurities Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…CertaraMarch 23, 2021
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence Publication Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…CertaraMarch 18, 2021
Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1% Publication Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1% CertaraMarch 16, 2021
Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge? Press Coverage Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge? By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…CertaraMarch 10, 2021
PK Submit CDISC Technology Video PK Submit CDISC Technology PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…CertaraMarch 10, 2021
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations On-Demand Webinar IQ WG Evaluation of PBPK Models for Organ-Impaired Populations • The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…CertaraMarch 10, 2021
R Speaks NLME (RsNLME) Brochure R Speaks NLME (RsNLME) Download the brochure to learn more about RsNLME’s features and benefits.CertaraMarch 9, 2021